The ProHance story: the making of a novel MRI contrast agent

[1]  P. Wedeking,et al.  Biodistribution of Radiolabeled, Formulated Gadopentetate, Gadoteridol, Gadoterate, and Gadodiamide in Mice and Rats , 1995, Investigative radiology.

[2]  V. Haughton,et al.  Enhancement of intervertebral disks with gadolinium complexes: comparison of an ionic and a nonionic medium in an animal model. , 1994, AJNR. American journal of neuroradiology.

[3]  Michael F. Tweedle,et al.  Synthesis, stability, and structure of gadolinium(III) and yttrium(III) macrocyclic poly(amino carboxylates) , 1994 .

[4]  C. Corot,et al.  Interaction of gadolinium complexes with metal-dependent biological systems. , 1994, Investigative radiology.

[5]  Y. Takehara,et al.  Acute hemodynamic effects of nonionic and ionic magnetic resonance contrast media in intravenous bolus injection in rats. , 1994, Investigative radiology.

[6]  M. Tweedle,et al.  Synthesis, characterization, and crystal structures of M(DO3A) (M = Fe, Gd) and Na[M(DOTA)] (M = Fe, Y, Gd) , 1993 .

[7]  M. Tweedle,et al.  Equilibrium and Kinetic Studies of Lanthanide Complexes of Macrocyclic Polyamino Carboxylates , 1993 .

[8]  A. Nordenbo,et al.  Acute deterioration of myasthenia gravis after intravenous administration of gadolinium-DTPA , 1992, The Lancet.

[9]  K. Urich,et al.  Quantification of dechelation of gadopentetate dimeglumine in rats. , 1992, Arzneimittel-Forschung.

[10]  J. Baños,et al.  Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction , 1991, British journal of pharmacology.

[11]  H. Weinmann,et al.  Gallium-67/stable gadolinium antagonism. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  M. Tweedle.  Nonionic or neutral? , 1991, Radiology.

[13]  J. M. Garrison,et al.  pH dependence of relaxivities and hydration numbers of gadolinium(III) complexes of macrocyclic amino carboxylates , 1990 .

[14]  B. Biagi,et al.  Gadolinium blocks low- and high-threshold calcium currents in pituitary cells. , 1990, The American journal of physiology.

[15]  J. Hagan,et al.  Fluorescence detection of gadolinium chelates separated by reversed-phase high-performance liquid chromatography , 1988 .

[16]  P. Wedeking,et al.  Dissociation of gadolinium chelates in mice: relationship to chemical characteristics. , 1992, Magnetic resonance imaging.

[17]  K. Houk,et al.  Molecular and Crystal Structure of a Lanthanide Complex, DyDTPA--BMA Hydrate. , 1992 .

[18]  J. Hagan,et al.  Reaction of gadolinium chelates with endogenously available ions. , 1991, Magnetic resonance imaging.

[19]  W. Cacheris,et al.  The relationship between thermodynamics and the toxicity of gadolinium complexes. , 1990, Magnetic resonance imaging.

[20]  P. Wedeking,et al.  Comparison of the biodistribution of 153Gd-labeled Gd(DTPA)2-, Gd(DOTA)-, and Gd(acetate)n in mice. , 1988, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[21]  H. Gries,et al.  Some physicochemical properties of the gadolinium-DTPA complex, a contrast agent for MRI. , 1984, Physiological chemistry and physics and medical NMR.